The rankings of the top pharmaceutical companies in the world in 2017 presented ... Abbott and AbbVie also increased their market cap by more than 50% in 2017, supported by their promising late ...

With the recent rise of diseases, pharmaceutical companies are pushing boundaries in medicine, from life-saving treatments to ...

When it comes to claiming market control, pharmaceutical companies stand apart from healthcare’s other monopolies. Whereas hospitals and health systems rely primarily on mergers and acquisitions ...

At the heart of this evolution lies the growing prominence of biologics contract manufacturing, a strategic partnership that is reshaping the way pharmaceutical companies approach their production ...

Finbold has selected three interesting pharmaceutical stocks that could see significant moves to the upside in 2025.

The report is based on insights from multiple interviews of global lifesciences leaders about their GenAI journey, primary research from HFS Pulse, and lifesciences HFS Horizon, and Indegene ...

The global pharmaceutical industry will generate more than $1.2 trillion in sales in 2025, according to Statista. A large portion of that figure is from the oncology segment, which is expected to ...